Founders Creative Accelerator Info Session Launches for AI Startups

Venture funding for Artificial Intelligence startups has surged while infrastructure costs drop, setting the stage for new growth.

The Founders Creative Accelerator is offering an innovative program for prospective Artificial Intelligence entrepreneurs looking to bring their startup ideas to life, even part-time. The accelerator is designed for builders who want to develop a minimum viable product (MVP), create a compelling pitch, and prepare for pre-seed or seed fundraising — all while maintaining their current jobs.

The three-month program provides participants with workshops, mentorship, and introductions to investors. This initiative comes at a time when global venture funding for Artificial Intelligence startups has surged by 52%, signaling an influx in investment and interest in the field. With technological infrastructure costs decreasing, the environment is poised for innovators to enter the market.

Participants can apply for the accelerator by March 31 to take advantage of special pricing. The program targets product leaders, builders, and operators transitioning to founding roles, aiming to support them from ideation to fundraising readiness. The Founders Creative Accelerator is hosting an info session to provide more insights about the program and answer potential applicants’ questions.

65

Impact Score

Crescent library brings privacy to digital identity systems

Crescent is a cryptographic library that adds unlinkability to common digital identity formats, preventing tracking across credential uses while preserving selective disclosure. It supports JSON Web Tokens and mobile driver’s licenses without requiring issuers to change their systems.

Artificial Intelligence-powered remote drug testing removes barriers to recovery

Q2i and King’s College London are collaborating to evaluate an Artificial Intelligence-powered at-home drug testing system aimed at people recovering from opioid use disorder. The solution delivers digitally observed, clinically reliable results and pairs testing with contingency management and telehealth to reduce logistical barriers to care.

Contact Us

Got questions? Use the form to contact us.

Contact Form

Clicking next sends a verification code to your email. After verifying, you can enter your message.